Advertisement

PharmacoEconomics & Outcomes News

, Volume 818, Issue 1, pp 29–29 | Cite as

Switch from Ferinject to Monofer reduces infusions and costs

Clinical study
  • 14 Downloads

Reference

  1. Pollock RF, et al. An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark. Advances in Therapy : 19 Nov 2018. Available from: URL: http://doi.org/10.1007/s12325-018-0827-5

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations